Yayınlar & Eserler

Yayın Ağı
Makaleler 167
Tümü (167)
SCI-E, SSCI, AHCI (161)
SCI-E, SSCI, AHCI, ESCI (165)
ESCI (4)
Scopus (161)
TRDizin (3)

1. EndoBridge 2024: pearls and highlights

YILDIZ O. B., Armeni E., Balodimou C., Biondi B., Ciudin A., Fruhbeck G., et al.
HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM , cilt.24, sa.4, ss.923-946, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

2. EndoCompass Project: Research Roadmap for Reproductive and Developmental Endocrinology

Cools M., Krausz C., Juul A., Macut D., Andersen M. S., Andersson A., et al.
HORMONE RESEARCH IN PAEDIATRICS , cilt.98, sa.SUPPL 2, ss.121-143, 2025 (SCI-Expanded, Scopus) identifier identifier

3. Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: serum and skeletal muscle profile

Kutuk I. S., AKIN Ş., Demirel H., Mumusoglu S., Ciftci T., YILDIZ O. B.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , 2025 (SCI-Expanded, Scopus) identifier identifier

4. PCOS research from the past to the future

YILDIZ O. B.
NATURE REVIEWS ENDOCRINOLOGY , cilt.21, sa.11, ss.668-670, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

5. Data-driven subtypes of polycystic ovary syndrome and their association with clinical outcomes

Gao X., Zhao S., Du Y., Yang Z., Tian Y., Zhao J., et al.
NATURE MEDICINE , 2025 (SCI-Expanded, Scopus) identifier identifier

6. EndoCompass project: research roadmap for reproductive and developmental endocrinology

Cools M., Krausz C., Juul A., Macut D., Andersen M. S., Andersson A., et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.193, 2025 (SCI-Expanded, Scopus) identifier identifier

7. Best practice recommendations for the diagnosis and management of hypoparathyroidism

Khan A. A., Ali D. S., Bilezikian J. P., Bjornsdottir S., Collins M. T., Cusano N. E., et al.
METABOLISM-CLINICAL AND EXPERIMENTAL , cilt.171, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

8. Structural and hormonal changes in the ovaries of women with polycystic ovary syndrome and healthy controls: a 13-year prospective study in an unselected population

Sonu N. C., Aksun S., Bozdag G., Yarali H., YILDIZ O. B., Mumusoglu S.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY , cilt.23, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

9. Impact of ultra-processed foods on hedonic and homeostatic appetite regulation: A systematic review

ULUĞ E., AÇIKGÖZ PINAR A., YILDIZ O. B.
APPETITE , cilt.213, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

10. Fasting and postprandial oxytocin and incretin dynamics in women with polycystic ovary syndrome and healthy controls

Gunesli I., ULUĞ E., AÇIKGÖZ PINAR A., Portakal O., YILDIZ O. B.
EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.193, sa.2, ss.255-261, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

11. Impact of oral contraceptive use on muscle mass and strength in women with PCOS

AKSUN ŞAHİN ., KARAÇOBAN L., İDİLMAN İ. S., YILDIZ O. B.
ENDOCRINE , cilt.89, sa.2, ss.647-654, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

12. GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity

ÇELİK Ö., Yazici D., Ciudin A., Macut D., Micic D., YUMUK V. D., et al.
OBESITY FACTS , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

13. The PCOS Phenotypes in Unselected Populations (P-PUP) study: participant clinical features and data harmonization on analysis of individual participant data

Bizuneh A. D., Kiconco S., Earnest A., Khomami M. B., Dhungana R. R., Azziz R., et al.
BMC MEDICINE , cilt.23, sa.1, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

14. Cardiometabolic Risk in First Degree Relatives of Women With Polycystic Ovary Syndrome (PCOS)

Chua S. J., Wu X., Al Kindi T., YILDIZ O. B., Mousa A., Pattuwage L., et al.
CLINICAL ENDOCRINOLOGY , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

15. Approach to the Patient: Hirsutism

Azziz R., Amiri M., Bril F., Joham A. E., Kelestimur F., Ottey S., et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , 2025 (SCI-Expanded, Scopus) identifier identifier

16. Polycystic ovary syndrome as a metabolic disease

Helvaci N., YILDIZ O. B.
NATURE REVIEWS ENDOCRINOLOGY , sa.4, ss.230-244, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

17. Comparative evaluation of ChatGPT-4, ChatGPT-3.5 and Google Gemini on PCOS assessment and management based on recommendations from the 2023 guideline

GÜNEŞLİ I., Aksun S., Fathelbab J., YILDIZ O. B.
ENDOCRINE , sa.1, ss.315-322, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

18. PCOS - the many faces of a disorder in women and men

GÜLERAY LAFCI N., YILMAZ B., YILDIZ O. B.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , sa.4, ss.785-798, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

19. The PCOS Phenotype in Unselected Populations study: ethnic variation in population-based normative cut-offs for defining hirsutism

Bizuneh A. D., Joham A. E., Tay C. T., Kiconco S., Earnest A., Dhungana R. R., et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY , sa.3, ss.228-239, 2025 (SCI-Expanded, Scopus) identifier identifier

20. Evaluating reliability, quality, and readability of ChatGPT's nutritional recommendations for women with polycystic ovary syndrome

ULUĞ E., GÜNEŞLİ I., Pinar A. A., YILDIZ O. B.
NUTRITION RESEARCH , cilt.133, ss.46-53, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

21. Ethnicity and the Prevalence of Polycystic Ovary Syndrome: The Eastern Siberia PCOS Epidemiology and Phenotype Study

Suturina L., Lizneva D., Lazareva L., Danusevich I., Nadeliaeva I., Belenkaya L., et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.110, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

22. European survey of diagnosis and management of the polycystic ovary syndrome: full report on the ESE PCOS Special Interest Group's 2023 Questionnaire

Livadas S., YILDIZ O. B., Mastorakos G., Gambineri A., Pignatelli D., Giorgino F., et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.191, sa.2, ss.134-143, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

23. Evaluation of muscle and bone composition and function in aging women with polycystic ovary syndrome

ÇELİK EROĞLU B., KARAÇOBAN L., İDİLMAN İ. S., KORKUSUZ F., YILDIZ O. B.
Maturitas , cilt.185, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

24. Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population

Aksun S., SONU N. C., AYGÜN S., KARAKULAK U. N., MÜMÜŞOĞLU S., YILDIZ O. B.
Journal of Endocrinological Investigation , cilt.47, sa.5, ss.1129-1137, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

25. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.

Goldberg A., Graca S., Liu J., Rao V., Witchel S. F., Pena A., et al.
Obesity reviews : an official journal of the International Association for the Study of Obesity , cilt.25, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

26. The prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome in treatment-naïve transgender people assigned female at birth

Oğuz S. H., BOYRAZ B. S., ERTÜRK B., YILDIZ O. B.
Endocrine , cilt.84, sa.1, ss.287-292, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

27. EndoBridge 2023: highlights and pearls

YILDIZ O. B., Boguszewski C. L., da Silva Boguszewski M. C., Busetto L., ÇELİK Ö., Fuleihan G. E., et al.
Hormones , 2024 (SCI-Expanded, Scopus) identifier identifier identifier

28. Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome

Teede H. J., Tay C. T., Laven J., Dokras A., Moran L. J., Piltonen T. T., et al.
Fertility and Sterility , cilt.120, sa.4, ss.767-793, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

29. Interleukin-22/Interleukin-22 binding protein axis and oral contraceptive use in polycystic ovary syndrome

Aksun S., ERSAL E., Portakal O., YILDIZ O. B.
Endocrine , cilt.81, sa.1, ss.54-57, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

30. Assessment of Type 2 Diabetes Risk in Young Women with Polycystic Ovary Syndrome

Livadas S., Paparodis R., Anagnostis P., Gambineri A., Bjekić-Macut J., Petrović T., et al.
Diagnostics , cilt.13, sa.12, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

31. Endocrine Disorders and COVID-19

Oguz S. H., YILDIZ O. B.
Annual review of medicine , cilt.74, ss.75-88, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

32. Current and emerging drug treatment strategies for polycystic ovary syndrome

Helvaci N., YILDIZ O. B.
EXPERT OPINION ON PHARMACOTHERAPY , cilt.24, ss.105-120, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

33. Establishing Normative Values to Determine the Prevalence of Biochemical Hyperandrogenism in Premenopausal Women of Different Ethnicities from Eastern Siberia

Suturina L., Lizneva D., Atalyan A., Lazareva L., Belskikh A., Bairova T., et al.
Diagnostics , cilt.13, sa.1, 2023 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

34. Use of anti-Mullerian hormone for understanding ovulatory dysfunction in polycystic ovarian syndrome

Mathyk B. A., Cetin E., YILDIZ O. B.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY , cilt.29, sa.6, ss.528-534, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

35. Impact of social isolation during COVID-19 pandemic on health behaviors and weight management in women with polycystic ovary syndrome

EYÜPOĞLU N. D., Aksun S., Ozturk M., YILDIZ O. B.
EATING AND WEIGHT DISORDERS-STUDIES ON ANOREXIA BULIMIA AND OBESITY , cilt.27, sa.7, ss.2407-2413, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

36. The impact of ageing and menopause in women with polycystic ovary syndrome

Helvaci N., YILDIZ O. B.
CLINICAL ENDOCRINOLOGY , cilt.97, sa.3, ss.371-382, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

37. Polycystic ovary syndrome and gut microbiota

YILDIZ B.
FEBS OPEN BIO , cilt.12, ss.34-35, 2022 (SCI-Expanded, Scopus) identifier

38. Aging versus youth: Endocrine aspects of vulnerability for COVID-19

Oguz S. H., KOCA M., YILDIZ O. B.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS , cilt.23, sa.2, ss.185-204, 2022 (SCI-Expanded, SSCI, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

39. Investigation of taste function and eating behavior in women with polycystic ovary syndrome

Cetik S., Acikgoz A., Yildiz B. O.
Appetite , cilt.168, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

40. Glucagon-like peptide-1, a matter of taste?

Jensterle M., DeVries J. H., Battelino T., Battelino S., Yildiz B., Janez A.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS , cilt.22, sa.4, ss.763-775, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

41. PCOS Phenotype in Unselected Populations Study (P-PUP): Protocol for a Systematic Review and Defining PCOS Diagnostic Features with Pooled Individual Participant Data.

Kiconco S., Mousa A., Azziz R., Enticott J., Suturina L. V., Zhao X., et al.
Diagnostics (Basel, Switzerland) , cilt.11, sa.11, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

42. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause

Robeva R., Mladenovic D., Veskovic M., Hrncic D., Bjekic-Macut J., Stanojlovic O., et al.
MATURITAS , cilt.151, ss.22-30, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

43. One year of the pandemic - how European endocrinologists responded to the crisis : a statement from the European Society of Endocrinology

Giustina A., Marazuela M., Reincke M., YILDIZ O. B., Puig-Domingo M.
EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.185, sa.2, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

44. Integrating Transwomen and Female Athletes with Differences of Sex Development (DSD) into Elite Competition: The FIMS 2021 Consensus Statement.

Hamilton B. R., Lima G., Barrett J., Seal L., Kolliari-Turner A., Wang G., et al.
Sports medicine (Auckland, N.Z.) , cilt.51, ss.1401-1415, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

45. Publication outcome of research presented at the European Congress of Endocrinology: a web scraping-based analysis and critical appraisal.

Saygili E. S., Yildiz B. O.
Endocrine , cilt.72, ss.385-391, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

46. COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology

Puig-Domingo M., Marazuela M., YILDIZ O. B., Giustina A.
ENDOCRINE , cilt.72, sa.2, ss.301-316, 2021 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

47. An Update on Contraception in Polycystic Ovary Syndrome

Oguz S. H., YILDIZ O. B.
ENDOCRINOLOGY AND METABOLISM , cilt.36, sa.2, ss.296-311, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

48. Influence of ethnicity on different aspects of polycystic ovary syndrome: a systematic review.

Sendur S. N., Yildiz B. O.
Reproductive biomedicine online , cilt.42, ss.799-818, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

49. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population

Mammadova G., ÖZKUL KOÇAK C., YILMAZ IŞIKHAN S., AÇIKGÖZ A., YILDIZ O. B.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION , cilt.51, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

50. Weight management strategies for patients with PCOS: current perspectives.

Ozgen Saydam B., Yildiz B. O.
Expert review of endocrinology & metabolism , cilt.16, ss.49-62, 2021 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

51. Prevalence of Obesity and Its Impact on Outcome in Patients With COVID-19: A Systematic Review and Meta-Analysis.

Helvaci N., Eyupoglu N. D., Karabulut E., Yildiz B. O.
Frontiers in endocrinology , cilt.12, ss.598249, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

52. Polycystic Ovary Syndrome and Brain: An Update on Structural and Functional Studies.

Ozgen Saydam B., Yildiz B. O.
The Journal of clinical endocrinology and metabolism , cilt.106, 2021 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

53. Obesity and physical exercise.

Celik O., Yildiz B. O.
Minerva endocrinologica , cilt.46, ss.131-144, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

54. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome

EYÜPOĞLU N. D., ERGÜNAY K., AÇIKGÖZ PINAR A., AKYÖN YILMAZ Y., Yilmaz E., Yildiz B. O.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.105, sa.12, 2020 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

55. Polycystic ovary syndrome and aging: Health implications after menopause

Helvaci N., Yildiz B. O.
MATURITAS , cilt.139, ss.12-19, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

56. Tissue fat quantification by magnetic resonance imaging: proton density fat fraction in polycystic ovary syndrome

OĞUZ BAYKAL S. H., Idilman I., HELVACI N., ÇALIŞKAN GÜZELCE E., Eyupoglu D., KARÇAALTINCABA M., et al.
REPRODUCTIVE BIOMEDICINE ONLINE , cilt.41, sa.2, ss.329-334, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

57. Polycystic ovary syndrome phenotypes and prevalence: Differential impact of diagnostic criteria and clinical versus unselected population

MÜMÜŞOĞLU S., YILDIZ O. B.
Current Opinion in Endocrine and Metabolic Research , cilt.12, ss.66-71, 2020 (Scopus) identifier

58. Cardiovascular health and menopause in aging women with polycystic ovary syndrome

Helvaci N., Yildiz B. O.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM , cilt.15, sa.1, ss.29-39, 2020 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

59. Adiponectin levels decrease independently of body mass index and diabetes type after the normalization of hyperglycemia

METİN AKSU N., Yazgan Aksoy D., AKKAŞ M., ÇINAR N., Ucar F., YILDIZ O. B., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.50, sa.2, ss.312-315, 2020 (SCI-Expanded, Scopus, TRDizin) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

60. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.

Eyupoglu N., Caliskan G., Acikgoz A., Uyanik E., Bjørndal B., Berge R., et al.
Clinical endocrinology , cilt.91, ss.810-815, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

61. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource

Azziz R., Kintziger K., Li R., Laven J., Morin-Papunen L., Merkin S. S., et al.
HUMAN REPRODUCTION , cilt.34, sa.11, ss.2254-2265, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

62. Is muscle mechanical function altered in polycystic ovary syndrome?

Caliskan Guzelce E., Eyupoglu D., Torgutalp S., Aktoz F., Portakal O., Demirel H., et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS , cilt.300, sa.3, ss.771-776, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

63. Anti-Mullerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population

Bozdag G., Mumusoglu S., Coskun Z., Yarali H., Yildiz B.
REPRODUCTIVE BIOMEDICINE ONLINE , cilt.39, sa.3, ss.522-529, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

64. Prevalence of Metabolic Syndrome and Its Relation to Physical Activity and Nutrition in Azerbaijan

Mammadova A., Isikhan S., AÇIKGÖZ A., Yildiz B. O.
METABOLIC SYNDROME AND RELATED DISORDERS , cilt.17, sa.3, ss.160-166, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

65. Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus

Khan A. A., Koch C. A., Van Uum S., Baillargeon J. P., Bollerslev J., Brandi M. L., et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.180, sa.3, 2019 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

66. Prevalence and predictors of gestational diabetes mellitus: a nationwide multicentre prospective study

Aydin H., ÇELİK Ö., Yazici D., Altunok C., Tarcin O., Deyneli O., et al.
DIABETIC MEDICINE , cilt.36, sa.2, ss.221-227, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

67. Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study)

Sonmez A., Yumuk V., Haymana C., Demirci I., Barcin C., Kiyici S., et al.
OBESITY FACTS , cilt.12, sa.2, ss.167-178, 2019 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

68. Metabolic Syndrome During Menopause

MÜMÜŞOĞLU S., YILDIZ O. B.
CURRENT VASCULAR PHARMACOLOGY , cilt.17, sa.6, ss.595-603, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

69. Endocrinology of Hirsutism: From Androgens to Androgen Excess Disorders

Yilmaz B., Yildiz B. O.
HYPERANDROGENISM IN WOMEN: BEYOND POLYCYSTIC OVARY SYNDROME , cilt.53, ss.108-119, 2019 (SCI-Expanded, Scopus) identifier identifier identifier

70. The association of cardiorespiratory fitness, body mass index, and age with testosterone levels at screening of healthy men undergoing preventive medical examinations: The Cooper Center Longitudinal Study

DeFina L. F., Radford N. B., Leonard D., Wilson R. K., Cooper T. C., Clark S. M., et al.
MATURITAS , cilt.118, ss.1-6, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

71. Turkish nationwide survEy of glycemic and other Metabolic parameters of patients with Diabetes mellitus (TEMD study)

Sonmez A., Haymana C., BAYRAM F., Salman S., Dizdar O. S., GÜRKAN E., et al.
DIABETES RESEARCH AND CLINICAL PRACTICE , cilt.146, ss.138-147, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

72. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede H. J., Misso M. L., Costello M. F., Dokras A., Laven J., Moran L., et al.
CLINICAL ENDOCRINOLOGY , cilt.89, sa.3, ss.251-268, 2018 (SCI-Expanded, Scopus) identifier identifier identifier

73. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede H. J., Misso M. L., Costello M. F., Dokras A., Laven J., Moran L., et al.
HUMAN REPRODUCTION , cilt.33, sa.9, ss.1602-1618, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

74. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome

Teede H. J., Misso M. L., Costello M. F., Dokras A., Laven J., Moran L., et al.
FERTILITY AND STERILITY , cilt.110, sa.3, ss.364-379, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

75. Diabetes mellitus and insulin resistance in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis

YILMAZ B., Vellanki P., Ata B., Yildiz B. O.
FERTILITY AND STERILITY , cilt.110, sa.3, ss.523-547, 2018 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

76. Androgen Excess- Polycystic Ovary Syndrome Society: position statement on depression, anxiety, quality of life, and eating disorders in polycystic ovary syndrome

Dokras A., Stener-Victorin E., Yildiz B. O., Li R., Ottey S., Shah D., et al.
FERTILITY AND STERILITY , cilt.109, sa.5, ss.888-899, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

77. Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis

YILMAZ B., Vellanki P., Ata B., Yildiz B. O.
FERTILITY AND STERILITY , cilt.109, sa.2, ss.356-396, 2018 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

78. Polycystic ovary syndrome and the risk of obstructive sleep apnea: a meta-analysis and review of the literature

Helvaci N., KARABULUT E., DEMİR A. U., Yildiz B. O.
ENDOCRINE CONNECTIONS , cilt.6, sa.7, ss.437-445, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

79. An International Consortium Update: Pathophysiology, Diagnosis, and Treatment of Polycystic Ovarian Syndrome in Adolescence

Ibanez L., Oberfield S. E., Witchel S. F., Auchus R. J., Chang R. J., Codner E., et al.
HORMONE RESEARCH IN PAEDIATRICS , cilt.88, sa.6, ss.371-395, 2017 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

80. Structural imaging of the brain reveals decreased total brain and total gray matter volumes in obese but not in lean women with polycystic ovary syndrome compared to body mass index-matched counterparts

SAYDAM B., Has A. C., BOZDAĞ G., Oguz K. K., Yildiz B. O.
GYNECOLOGICAL ENDOCRINOLOGY , cilt.33, sa.7, ss.519-523, 2017 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

81. Suppressed Adiponectin Levels and Increased Adiponectin Response to Oral Glucose Load in Lean Women with Severe Acne Normalizes after Isotretinoin Treatment

Aydin K., Cetinozman F., ELÇİN G., Aksoy D. Y., Ucar F., Yildiz B. O.
DERMATOLOGY , cilt.233, sa.4, ss.314-319, 2017 (SCI-Expanded, Scopus) identifier identifier identifier

82. Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome

Orio F., Muscogiuri G., Nese C., Palomba S., Savastano S., Tafuri D., et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , cilt.207, ss.214-219, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

83. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis

BOZDAĞ G., MÜMÜŞOĞLU S., Zengin D., KARABULUT E., Yildiz B. O.
HUMAN REPRODUCTION , cilt.31, sa.12, ss.2841-2855, 2016 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

84. Polycystic ovary syndrome

Azziz R., CARMINA E., CHEN Z., Dunaif A., LAVEN J. S. E., LEGRO R. S., et al.
NATURE REVIEWS DISEASE PRIMERS , cilt.2, 2016 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

85. REPRODUCTIVE ENDOCRINOLOGY Contraceptives, exercise and diet - are all three needed in PCOS?

Yildiz B. O.
NATURE REVIEWS ENDOCRINOLOGY , cilt.12, sa.8, ss.438-439, 2016 (SCI-Expanded, Scopus) identifier identifier

86. Evolutionary determinants of polycystic ovary syndrome: part 1

ÜNLÜTÜRK U., SEZGİN E., Yildiz B. O.
FERTILITY AND STERILITY , cilt.106, sa.1, ss.33-41, 2016 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

87. Oxidative Stress and Periodontal Disease in Obesity

DURSUN E., Akalin F. A., Genc T., Cinar N., Erel O., Yildiz B. O.
MEDICINE , cilt.95, sa.12, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

88. Response to the Letter by Alireza A., et al.

Yildiz B. O.
The Journal of clinical endocrinology and metabolism , cilt.101, 2016 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

89. Gut-Brain Axis and Metabolism in Polycystic Ovary Syndrome

SAYDAM B., Yildiz B. O.
CURRENT PHARMACEUTICAL DESIGN , cilt.22, sa.36, ss.5572-5587, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

90. Weight-sparing effect of insulin detemir: A consequence of central nervous system-mediated reduced energy intake?

Russell-Jones D., Danne T., Hermansen K., Niswender K., Robertson K., Thalange N., et al.
Diabetes, Obesity and Metabolism , cilt.17, sa.10, ss.919-927, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

91. New insights into the mechanisms of diastolic dysfunction in patients with type 2 diabetes

Bayraktar A., Canpolat U., Demiri E., Kunak A. U., ÖZER N., AKSÖYEK S., et al.
SCANDINAVIAN CARDIOVASCULAR JOURNAL , cilt.49, sa.3, ss.142-148, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

92. Turkish hypertension consensus report

ARICI M., BİRDANE A., Guler K., Yildiz B. O., ALTUN B., ERTÜRK Ş., et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.43, sa.4, ss.402-409, 2015 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier identifier

93. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome

CINAR N., CETINOZMAN F., AKSOY D. Y., ELÇİN G., YILDIZ B.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY , cilt.29, sa.5, ss.875-880, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

94. Approach to the Patient: Contraception in Women With Polycystic Ovary Syndrome

Yildiz B. O.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.100, sa.3, ss.794-802, 2015 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

95. European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group's Questionnaire

Conway G., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H. F., Franks S., Gambineri A., et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.171, sa.4, ss.489-498, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

96. Fasting and post-prandial glucagon like peptide 1 and oral contraception in polycystic ovary syndrome

Aydin K., Arusoglu G., KÖKSAL G., Cinar N., Aksoy D. Y., Yildiz B. O.
CLINICAL ENDOCRINOLOGY , cilt.81, sa.4, ss.588-592, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

97. The polycystic ovary syndrome: a position statement from the European Society of Endocrinology

Conway G., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H. F., Franks S., Gambineri A., et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY , cilt.171, sa.4, 2014 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

98. Oral contraceptives in polycystic ovary syndrome

Helvaci N., Yildiz B. O.
MINERVA ENDOCRINOLOGICA , cilt.39, sa.3, ss.175-187, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

99. Insulin sensitivity, androgens and isotretinoin therapy in women with severe acne

CETINOZMAN F., AKSOY D. Y., Elcin G., YILDIZ B.
JOURNAL OF DERMATOLOGICAL TREATMENT , cilt.25, sa.2, ss.119-122, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

100. Vitamin D status and seasonal changes in plasma concentrations of 25-hydroxyvitamin D in office workers in Ankara, Turkey

Cinar N., HARMANCI A., Yildiz B. O., BAYRAKTAR M.
EUROPEAN JOURNAL OF INTERNAL MEDICINE , cilt.25, sa.2, ss.197-201, 2014 (SCI-Expanded, Scopus) identifier identifier identifier

101. Basal and Meal-Stimulated Ghrelin, PYY, CCK Levels and Satiety in Lean Women With Polycystic Ovary Syndrome: Effect of Low-Dose Oral Contraceptive

Arusoglu G., KÖKSAL G., Cinar N., Tapan S., Aksoy D. Y., Yildiz B. O.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.98, sa.11, ss.4475-4482, 2013 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

102. Effects of L-Thyroxine on Gastric Motility and Ghrelin in Subclinical Hypothyroidism: A Prospective Study

CANPOLAT A. G., KAV T., SİVRİ B., YILDIZ B. O.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.98, sa.11, 2013 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

103. Polycystic ovary syndrome: is obesity a symptom?

Yildiz B. O.
WOMENS HEALTH , cilt.9, sa.6, ss.505-507, 2013 (ESCI, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

104. Interventions for the metabolic dysfunction in polycystic ovary syndrome

BOZDAĞ G., Yildiz B. O.
STEROIDS , cilt.78, sa.8, ss.777-781, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

105. Referral Bias in Defining the Phenotype and Prevalence of Obesity in Polycystic Ovary Syndrome

Ezeh U., Yildiz B. O., Azziz R.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.98, sa.6, 2013 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

106. Effects of L-Thyroxine Therapy on Circulating Leptin and Adiponectin Levels in Subclinical Hypothyroidism: A Prospective Study

Yildiz B. O., Aksoy D. Y., HARMANCI A., ÜNLÜTÜRK U., Cinar N., Isildak M., et al.
ARCHIVES OF MEDICAL RESEARCH , cilt.44, sa.4, ss.317-320, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

107. 25-OH-Vitamin D and procalcitonin levels after correction of acute hyperglycemia

METİN AKSU N., Aksoy D. Y., AKKAŞ M., Yilmaz H., Akman C., Yildiz B. O., et al.
MEDICAL SCIENCE MONITOR , cilt.19, ss.264-268, 2013 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

108. Ethinyl estradiol-drospirenone vs ethinyl estradiol-drospirenone plus metformin in the treatment of lean women with polycystic ovary syndrome

Cinar N., HARMANCI A., BAYRAKTAR M., Yildiz B. O.
CLINICAL ENDOCRINOLOGY , cilt.78, sa.3, ss.379-384, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

109. Body composition in lean women with polycystic ovary syndrome: effect of ethinyl estradiol and drospirenone combination

Aydin K., Cinar N., Aksoy D. Y., BOZDAĞ G., Yildiz B. O.
CONTRACEPTION , cilt.87, sa.3, ss.358-362, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

110. Serum resistin and high sensitive CRP levels in patients with subclinical hypothyroidism before and after L-thyroxine therapy

Aksoy D. Y., Cinar N., Harmanci A., Karakaya J., Yildiz B. O., Usman A., et al.
MEDICAL SCIENCE MONITOR , cilt.19, ss.210-215, 2013 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

111. The Efficacy and Safety of Triple vs Dual Combination of Angiotensin II Receptor Blocker and Calcium Channel Blocker and Diuretic: A Systematic Review and Meta-Analysis

Kizilirmak P., Berktas M., Uresin Y., YILDIZ O. B.
JOURNAL OF CLINICAL HYPERTENSION , cilt.15, sa.3, ss.193-200, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

112. Polycystic Ovary Syndrome Novel Insights into Causes and Therapy Preface

Macut D., Pfeifer M., YILDIZ O. B., Diamanti-Kandarakis E.
POLYCYSTIC OVARY SYNDROME: NOVEL INSIGHT INTO CAUSES AND THERAPY , cilt.40, 2013 (SCI-Expanded) identifier

113. Combined Oral Contraceptives in Polycystic Ovary Syndrome - Indications and Cautions

BOZDAĞ G., Yildiz B. O.
POLYCYSTIC OVARY SYNDROME: NOVEL INSIGHT INTO CAUSES AND THERAPY , cilt.40, ss.115-127, 2013 (SCI-Expanded) identifier

114. Oral contraceptive plus antiandrogen therapy and cardiometabolic risk in polycystic ovary syndrome

HARMANCI A., Cinar N., BAYRAKTAR M., Yildiz B. O.
CLINICAL ENDOCRINOLOGY , cilt.78, sa.1, ss.120-125, 2013 (SCI-Expanded, Scopus) identifier identifier identifier

115. Adrenocortical steroid response to ACTH in different phenotypes of non-obese polycystic ovary syndrome

Cinar N., HARMANCI A., Aksoy D. Y., Aydin K., Yildiz B. O.
JOURNAL OF OVARIAN RESEARCH , cilt.5, 2012 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

116. Family planning 2011: better use of existing methods, new strategies and more informed choices for female contraception The ESHRE Capri Workshop Group

Baird D. T., Evers J. L. H., Gemzell-Danielsson K., Glasier A., Killick S. R., Van Look P. F. A., et al.
HUMAN REPRODUCTION UPDATE , cilt.18, sa.6, ss.670-681, 2012 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

117. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria

Yildiz B. O., BOZDAĞ G., Yapici Z., ESİNLER İ., YARALI H.
HUMAN REPRODUCTION , cilt.27, sa.10, ss.3067-3073, 2012 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

118. Effect of an oral contraceptive on emotional distress, anxiety and depression of women with polycystic ovary syndrome: a prospective study

Cinar N., HARMANCI A., DEMİR B., Yildiz B. O.
HUMAN REPRODUCTION , cilt.27, sa.6, ss.1840-1845, 2012 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

119. Consensus on women's health aspects of polycystic ovary syndrome (PCOS)

Fauser B. C. J. M., Tarlatzis B. C., Rebar R. W., Legro R. S., Balen A. H., Lobo R., et al.
HUMAN REPRODUCTION , cilt.27, sa.1, ss.14-24, 2012 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

120. Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group

Fauser B. C. J. M., Tarlatzis B. C., Rebar R. W., Legro R. S., Balen A. H., Lobo R., et al.
FERTILITY AND STERILITY , cilt.97, sa.1, ss.28-63, 2012 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

121. Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome

Cinar N., Kizilarslanoglu M. C., HARMANCI A., Aksoy D. Y., BOZDAĞ G., DEMİR B., et al.
HUMAN REPRODUCTION , cilt.26, sa.12, ss.3339-3345, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

122. PCOS Forum: research in polycystic ovary syndrome today and tomorrow

Pasquali R., Stener-Victorin E., Yildiz B. O., Duleba A. J., Hoeger K., Mason H., et al.
CLINICAL ENDOCRINOLOGY , cilt.74, sa.4, ss.424-433, 2011 (SCI-Expanded, Scopus) identifier identifier identifier

123. Periodontal disease in polycystic ovary syndrome

DURSUN E., AKALIN F. A., GÜNCÜ G. N., ÇINAR N., HARMANCI A., KARABULUT E.
FERTILITY AND STERILITY , cilt.95, sa.1, ss.320-323, 2011 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

124. Ovarian and adipose tissue dysfunction in polycystic ovary syndrome: report of the 4th special scientific meeting of the Androgen Excess and PCOS Society

Yildiz B. O., Azziz R.
FERTILITY AND STERILITY , cilt.94, sa.2, ss.690-693, 2010 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

125. Increased circulating soluble P-selectin in polycystic ovary syndrome

Yildiz B. O., BOZDAĞ G., HARMANCI A., Otegen U., Boynukalin K., Vural Z., et al.
FERTILITY AND STERILITY , cilt.93, sa.7, ss.2311-2315, 2010 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

126. Dynamics of Nampt/visfatin and high molecular weight adiponectin in response to oral glucose load in obese and lean women

ÜNLÜTÜRK U., HARMANCI A., Yildiz B. O., BAYRAKTAR M.
CLINICAL ENDOCRINOLOGY , cilt.72, sa.4, ss.469-474, 2010 (SCI-Expanded, Scopus) identifier identifier identifier

127. Regulation of Adiponectin Secretion by Adipocytes in the Polycystic Ovary Syndrome: Role of Tumor Necrosis Factor-alpha

Chazenbalk G., Trivax B. S., Yildiz B. O., Bertolotto C., Mathur R., Heneidi S., et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.95, sa.2, ss.935-942, 2010 (SCI-Expanded, Scopus) Creative Commons License identifier identifier

128. Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS

Yildiz B. O., BOZDAĞ G., Otegen U., HARMANCI A., Boynukalin K., Vural Z., et al.
REPRODUCTIVE BIOMEDICINE ONLINE , cilt.20, sa.1, ss.150-155, 2010 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

129. Visually scoring hirsutism

Yildiz B. O., Bolour S., Woods K., Moore A., Azziz R.
HUMAN REPRODUCTION UPDATE , cilt.16, sa.1, ss.51-64, 2010 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

130. Insulin resistance in polycystic ovary syndrome: Maker or marker?

BOZDAĞ G., YILDIZ B.
Expert Review of Obstetrics and Gynecology , cilt.5, sa.1, ss.67-75, 2010 (AHCI) identifier identifier

131. Assessment, diagnosis and treatment of a patient with hirsutism

Yildiz B. O.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM , cilt.4, sa.5, ss.294-300, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

132. Autoimmune polyendocrine syndrome with atrial septal defect

Aksoy D. Y., Agbaht K., Harmanci O., Karadag O., Aytemir K., Sungur A., et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES , cilt.335, sa.2, ss.157-159, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

133. Oral contraceptives in polycystic ovary syndrome: Risk-benefit assessment

Yildiz B. O.
SEMINARS IN REPRODUCTIVE MEDICINE , cilt.26, sa.1, ss.111-120, 2008 (SCI-Expanded, Scopus) identifier identifier identifier

134. Impact of obesity on the risk for polycystic ovary syndrome

Yildiz B. O., Knochenhauer E. S., Azziz R.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.93, sa.1, ss.162-168, 2008 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

135. Linkage Analysis in a Large Primary Osteoporosis Family

Balci B., Yildiz B. O., Ofir R., Dincer P., BAYRAKTAR M.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.33, sa.4, ss.215-222, 2008 (SCI-Expanded, TRDizin) Sürdürülebilir Kalkınma identifier

136. The adrenal and polycystic ovary syndrome

Yildiz B. O., Azziz R.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS , cilt.8, sa.4, ss.331-342, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

137. Correlation of adrenocorticotropin steroid levels between women with polycystic ovary syndrome and their sisters

Goodarzi M. O., Guo X., Yildiz B. O., Stanczyk F. Z., Azziz R.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY , cilt.196, sa.4, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

138. Hormonal and Biochemical Evaluation of Polycystic Ovary Syndrome

Yildiz B. O.
INSULIN RESISTANCE AND POLYCYSTIC OVARIAN SYNDROME: PATHOGENESIS, EVALUATION, AND TREATMENT , ss.159-166, 2007 (SCI-Expanded) identifier

139. Adrenocortical dysfunction in polycystic ovary syndrome

Yildiz B. O., Azziz R.
POLYCYSTIC OVARY SYNDROME, 2ND EDITION , ss.288-315, 2007 (SCI-Expanded) identifier

140. The Genetic Basis of the Polycystic Ovary Syndrome: A Literature Review Including Discussion of PPAR-gamma

UNLUTURK U., Harmanci A., Kocaefe C., YILDIZ B.
PPAR RESEARCH , cilt.2007, 2007 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

141. Heritability of dehydroepiandrosterone sulfate in women with polycystic ovary syndrome and their sisters

Yildiz B. O., Goodarzi M. O., Guo X., Rotter J. I., Azziz R.
FERTILITY AND STERILITY , cilt.86, sa.6, ss.1688-1693, 2006 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

142. Prevalence of glutamic acid decarboxylase antibody positivity and its association with insulin secretion and sensitivity in autoimmune thyroid disease: A pilot study

Aksoy D. Y., Yurekli B. P. S., Yildiz B. O., Gedik O.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES , cilt.114, sa.8, ss.412-416, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

143. Diagnosis of hyperandrogenism: clinical criteria

YILDIZ O. B.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.20, sa.2, ss.167-176, 2006 (SCI-Expanded, Scopus) identifier identifier identifier

144. Rethinking leptin and insulin action: Therapeutic opportunities for diabetes

Yildiz B., Haznedaroglu I.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY , cilt.38, ss.820-830, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

145. Masking effect of endogenous hypercortisolism on vasculitis

Cankurtaran M., Dagdelen S., Apra S., Yildiz B., Kiraz S., Firat P., et al.
ENDOCRINOLOGIST , cilt.15, sa.5, ss.281-285, 2005 (SCI-Expanded, Scopus) identifier identifier

146. Effect of leptin replacement on brain structure in genetically leptin-deficient adults

Matochik J., London E., YILDIZ O. B., Ozata M., Caglayan S., DePaoli A., et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.90, sa.5, ss.2851-2854, 2005 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

147. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome

Yildiz B., Woods K., Stanczyk F., Bartolucci A., Azziz R.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.89, sa.11, ss.5558-5562, 2004 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

148. Recent advances in the treatment of polycystic ovary syndrome

Yildiz B.
EXPERT OPINION ON INVESTIGATIONAL DRUGS , cilt.13, sa.10, ss.1295-1305, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

149. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity

YILDIZ O. B., Suchard M., Wong M., McCann S., Licinio J.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.101, sa.28, ss.10434-10439, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

150. The prevalence and features of the polycystic ovary syndrome in an unselected population

Azziz R., Woods K., Reyna R., Key T., Knochenhauer E., Yildiz B.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.89, sa.6, ss.2745-2749, 2004 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

151. Assessment of glucose intolerance and insulin sensitivity in polycystic ovary syndrome

Yildiz B., Gedik O.
REPRODUCTIVE BIOMEDICINE ONLINE , cilt.8, sa.6, ss.649-656, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

152. A patient presenting with spinal cord compression who had two distinct follicular cell type thyroid carcinomas

Koca E., Sokmensuer C., Yildiz B., Engin H., Bozkurt M., Aras T., et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION , cilt.27, sa.6, ss.562-564, 2004 (SCI-Expanded, Scopus) identifier identifier identifier

153. Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults

Licinio J., Caglayan S., Ozata M., YILDIZ O. B., de Miranda P., O'Kirwan F., et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA , cilt.101, sa.13, ss.4531-4536, 2004 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

154. Simultaneous and continuous 24-hour plasma and cerebrospinal fluid leptin measurements: Dissociation of concentrations in central and peripheral compartments

Wong M., Licinio J., YILDIZ O. B., Mantzoros C., Prolo P., Kling M., et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.89, sa.1, ss.258-265, 2004 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

155. Polycystic ovary syndrome and ovulation induction

YILDIZ O. B., CHANG W., AZZIZ R.
MINERVA GINECOLOGICA , cilt.55, sa.5, ss.425-439, 2003 (Scopus) identifier identifier

156. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome

Yildiz B., Yarali H., Oguz H., Bayraktar M.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.88, sa.5, ss.2031-2036, 2003 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

157. Metformin and FSH for induction of ovulation in women with polycystic ovary syndrome

Yarali H., Yildiz B.
HUMAN REPRODUCTION , cilt.17, sa.11, ss.3007-3008, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

158. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state

Yildiz B., Haznedaroglu I., Kirazli S., Bayraktar M.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.87, sa.8, ss.3871-3875, 2002 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier

159. Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial

Yarali H., Yildiz B., Demirol A., Zeyneloglu H., Yigit N., Bukulmez O., et al.
HUMAN REPRODUCTION , cilt.17, sa.2, ss.289-294, 2002 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

160. Depression and cardiovascular disease: co-occurrence or shared genetic substrates?

Licinio J., YILDIZ O. B., Wong M.
MOLECULAR PSYCHIATRY , cilt.7, sa.10, ss.1031-1032, 2002 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

161. Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia

YILDIZ O. B., Gedik O.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY , cilt.100, sa.1, ss.62-66, 2001 (SCI-Expanded, Scopus) identifier identifier identifier

162. Metabolic characteristics of individuals with varying degrees of glucose tolerance

YILDIZ O. B., Gurlek A., Bayraktar M.
DIABETES , cilt.50, 2001 (SCI-Expanded, Scopus) identifier

163. A large consanguineous osteoporosis family with 20 affected individuals

Dincer P. R., YILDIZ O. B., Balci B., Bayraktar M.
BONE , cilt.28, sa.5, 2001 (SCI-Expanded) identifier

164. Insulin resistance in individuals with family history of diabetes: Low HDL-cholesterol versus normal HDL cholesterol

YILDIZ O. B., Gurlek A., Bayraktar M.
ATHEROSCLEROSIS , cilt.146, 1999 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

165. Failure of sulfonylureas in type 2 diabetes

YILDIZ O. B., Gurlek A.
HORMONE AND METABOLIC RESEARCH , cilt.31, sa.4, ss.293, 1999 (SCI-Expanded, Scopus) identifier identifier identifier

166. Albendazole-induced amegakaryocytic thrombocytopenic purpura

YILDIZ O. B., Haznedaroglu I., Coplu L.
ANNALS OF PHARMACOTHERAPY , cilt.32, ss.842, 1998 (SCI-Expanded, Scopus) identifier identifier identifier

167. Acute Budd-Chiari syndrome associated with activated protein C resistance during intravenous anticoagulant treatment

YILDIZ O. B., Oran B., Buyukasik Y., Haznedaroglu I., Cekirge S., Kirazli S.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.4, sa.3, ss.220-223, 1998 (SCI-Expanded, Scopus) identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 15

1. Is Muscle Mechanical Function Altered In Polycystic Ovary Syndrome?

ÇALIŞKAN E., TORĞUTALP Ş. Ş., AKTOZ F., PORTAKAL AKÇİN O., DEMİREL A. H., YILDIZ O. B.
ENDO 2019, NEW ORLEANS, Amerika Birleşik Devletleri, 23 - 26 Mart 2019, cilt.3, (Tam Metin Bildiri)

2. Gut - brain axis and metabolism in PCOS

YILDIZ O. B.
6th Slovenian Congress of Endocrinology, Bled, Slovenya, 22 - 24 Kasım 2018, ss.117-118, (Tam Metin Bildiri)

3. Microbiota and metabolic disorders

YILDIZ O. B.
23rd ESE Postgraduate Training Course on Endocrinology, Diabetes and Metabolism, Minsk, Belarus, 9 - 11 Kasım 2018, (Özet Bildiri)

4. Prevalence and predictors of gestational diabetes mellitus: a nationwide multicenter prospective study

AYDIN H., ÇELİK Ö., YAZICI D., ALTUNOK E. Ç., TARÇIN Ö., DEYNELİ O., et al.
20th European Congress of Endocrinology 2018, Barselona, İspanya, 19 - 22 Mayıs 2018, cilt.56, ss.115, (Özet Bildiri)

5. Current and eveolving concepts in PCOS

YILDIZ O. B.
The 6th Seoul INternational Congress of Endocrinology and Metabolism, Seul, Güney Kore, 19 - 22 Nisan 2018, (Özet Bildiri)

6. Quantitative evaluation of certain bacterial groups in patients with polycystic ovary syndrome

Mamedova G., ERDOĞDU C., AKYÖN YILMAZ Y., YILDIZ O. B.
XXXth International Workshop on Helicobacter Microbiota in Inflammation Cancer, 7 - 09 Eylül 2017, (Tam Metin Bildiri)

7. Quantitative evaluation of certain bacterial groups in patients with polycystic ovary syndrome

Mamedova G., Ozkul C., Akyon Y., YILDIZ O. B.
30th International Workshop of the European-Helicobacter-and-Microbiota-Study-Group (EHMSG) on Helicobacter and Microbiota in Inflammation and Cancer, Bordeaux, Fransa, 7 - 09 Eylül 2017, cilt.22, (Özet Bildiri) identifier

8. Prevalence of metabolic syndrome and its relation to physical activity and nutrition in Azerbaijan

MAMMADOVA A., YILMAZ IŞIKHAN S., AÇIKGÖZ A., YILDIZ O. B.
19th European Congress of Endocrinology 2017, Lisbon, Portekiz, 20 - 23 Mayıs 2017, cilt.49, ss.268-269, (Özet Bildiri)

9. Comparison of morphological findings by two- and three-dimensional ultrasound in patients with polycystic ovary syndrome and otherwise healthy women

Coskun Z. Y., Bozdag G., Yildiz B. O., Esinler I., Yarali H.
28th Annual Meeting of the European-Society-of-Human-Reproduction-and-Embryology (ESHRE), İstanbul, Türkiye, 1 - 04 Temmuz 2012, cilt.27, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

10. A look at the Past: History of Rimonabant

Aydinkarahaliloglu D. N., Aykac E., Kasap Y., Sagis G., Babacanoglu C., Ilbars H., et al.
11th Annual Meeting of the International-Society-of-Pharmacovigilance (ISoP) on Next Stop - Istanbul-Bridging the Continents, İstanbul, Türkiye, 26 - 28 Ekim 2011, cilt.34, ss.1007-1008, (Özet Bildiri) identifier

11. Investigating of oral constraceptives effects on weight gaining mechanisms in polycystic ovary sendrome (PCOS) patients

YANIK T., Sezlev D., Yildiz B. O.
9th International Meeting of the International-Society-for-the-Study-of-Xenobiotics(ISSX), İstanbul, Türkiye, 4 - 08 Eylül 2010, cilt.42, ss.160-161, (Özet Bildiri) identifier

12. Periodontal Disease in Polycystic Ovary Syndrome

DURSUN E., GÜNCÜ G. N., ÇINAR N., HARMANCI A., ÖZBEK Ş. M., KARABULUT E., et al.
11th European Congress of Endocrinology (ECE), 26 - 29 Eylül 2009, (Özet Bildiri)

13. Periodontal status and oxidative markers in patients with policyctic ovary syndrome

GÜNCÜ G. N., DURSUN E., KILINÇ K., YILDIZ O. B., AKALIN F. A.
Europerio 6 6th Congress of the European Federation of Periodontology, 4 - 06 Haziran 2009, cilt.36, ss.7, (Özet Bildiri)

14. Impact of diagnostic criteria - NICHD versus Rotterdam

Yildiz B. O.
2nd Annual Peacocks Polycystic Ovary Syndrome Forum on Current Controversies form the Ovary to the Pancreas, Spaltenna, İtalya, 27 - 30 Eylül 2007, ss.333-344, (Tam Metin Bildiri) Sürdürülebilir Kalkınma identifier

15. Comparative effects of cisplatin on human and rat butyrylcholinesterases

BODUR E., YILDIZ O. B., Cokugras A. N., ÖZER N.
32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS), Vienna, Avusturya, 7 - 12 Temmuz 2007, cilt.274, ss.233, (Özet Bildiri) identifier
Kitaplar 14

1. Female Reproductive Endocrine Disorders

Yıldız O. B. (Editör)
Oxford Textbook of Diabetes and Endocrinology, John Wass,Wiebke Arlt,Robert Semple, Editör, Oxford University Press, London , Oxford, ss.1249-1418, 2022

2. Polycystic Ovary Syndrome: Hirsutism

Pıgnatellı D., Azzız R., Yıldız O. B.
Oxford Textbook of Endocrinology and Diabetes, John Wass,Wibke Arlt,Robert Semple, Editör, Oxford University Press, London , Oxford, ss.1334-1344, 2022

3. Polycystic Ovary Syndrome: Definitions, Phenotypes, Prevalence, and Genetics

Mümüşoğlu S., Yıldız O. B.
Oxford Textbook of Endocrinology and Diabetes, John Wass,Wiebke Arlt,Robert Semple, Editör, Oxford University Press, London , Oxford, ss.1313-1319, 2022

4. The endocrinology of aging

OĞUZ BAYKAL S. H., YILDIZ O. B.
Beauty, Aging and AntiAging, Ibrahim Vargel, Fatma Ozgur, Editör, Elsevier, Amsterdam, ss.303-318, 2022

5. Targeting metabolism in the management of PCOS: Metformin and beyond

OĞUZ BAYKAL S. H., ŞENDUR S. N., ÜNLÜTÜRK U., YILDIZ O. B.
Polycystic Ovary Syndrome Challenging Issues in the Modern Era of Individualized Medicine, Evanthia Diamanti-Kandarakis, Editör, Elsevier, Amsterdam, ss.117-133, 2021

6. Endocrinology of Hirsutism: From Androgens to Androgen Excess Disorders

Yilmaz B., YILDIZ O. B.
Hyperandrogenism in Women: Beyond Polycystic Ovary Syndrome, Pasquali Renato Pignatelli Duarte, Editör, Karger, Basel, ss.108-119, 2019

7. Yetişkinlerde Fiziksel Aktivite

Adsız F., Can S., İKİIŞIK H., DÖNMEZ G., ARDIÇ F., Demirsoy N., et al.
T C Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu Türkiye Fiziksel Aktivite Rehberi, Haydar Demirel, Hülya Kayıhan, Elif N. Özmert, Asuman Doğan, Editör, Kuban Matbaacılık Yayıncılık, Ankara, ss.41-55, 2014 Sürdürülebilir Kalkınma

8. Hirsutism

Yıldız O. B., Azziz R.
Oxford Textbook of Endocrinology and Diabetes, John A.H. Wass,Paul Stewart, Editör, Oxford University Press, London , New York, ss.1239-1248, 2011

9. Impact of diagnostic criteria: NICHD versus Rotterdam

Yıldız O. B.
Polycystic ovary syndrome: Current controversies from the ovary to the pancreas, Andrea Dunaif,R. Jeffrey Chang,Stephen Franks,Richard S. Legro, Editör, Humana Press, Inc. , New Jersey, ss.333-344, 2008

10. Hormonal and biochemical evaluation of polycystic ovary syndrome

Yıldız O. B.
Insulin Resistance and Polycystic Ovary Syndrome, Evanthia Diamanti-Kandarakis,John Nestler,Dimitrios Panidis,Renato Pasquali, Editör, Humana Press, Inc. , New Jersey, ss.159-166, 2007

11. Adrenocortical dysfunction in polycystic ovary syndrome

Yıldız O. B., Azziz R.
Polycystic Ovary Syndrome, Gabor Kovacs,Robert Norman, Editör, Cambridge University Press, Cambridge (MA), USA , Cambridge, ss.288-315, 2007

12. Hypothalamic-pituitary-adrenal dysfunction in the polycystic ovary syndrome

Yıldız O. B., Carmına E., Azzız R.
Androgen Excess Disorders in Women, Ricardo Azziz,John Nestler,Didier Dewailly, Editör, Humana Press, Inc. , New Jersey, ss.213-222, 2006

13. Polycystic ovary syndrome and ovulation induction

Yıldız O. B., Azzız R.
Androgen Excess Disorders in Women, Ricardo Azziz,John Nestler,Didier Dewailly, Editör, Humana Press, Inc. , New Jersey, ss.389-404, 2006

14. Endocrinology of the ovary

Magoffın D., Kumar A., Yıldız O. B., Azzız R.
Endocrinology: Basic and Clinical Principles, Shlomo Melmed,P. Michael Conn, Editör, Humana Press, Inc. , New Jersey, ss.391-404, 2005
Metrikler

Yayın

198

Yayın (WoS)

171

Yayın (Scopus)

161

Atıf (WoS)

13891

H-İndeks (WoS)

45

Atıf (Scopus)

14646

H-İndeks (Scopus)

45

Atıf (Scholar)

29197

H-İndeks (Scholar)

58

Atıf (Diğer Toplam)

2

Proje

26

Tez Danışmanlığı

7

Açık Erişim

59
BM Sürdürülebilir Kalkınma Amaçları